Cargando…

Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?

Detalles Bibliográficos
Autores principales:	Bellasi, Antonio, Di Iorio, Biagio Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090671/ https://www.ncbi.nlm.nih.gov/pubmed/25032144 http://dx.doi.org/10.5812/numonthly.18379

Ejemplares similares

Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019)

Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights
por: Di Micco, Lucia, et al.
Publicado: (2019)

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
por: Bellasi, Antonio, et al.
Publicado: (2016)

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
por: Bellasi, Antonio, et al.
Publicado: (2019)

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2019)

Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
por: Di Iorio, Biagio R., et al.
Publicado: (2020)

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2019)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Associations of Calcium from Food Sources versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients
por: Mahdavi, Sara, et al.
Publicado: (2019)

Kidney Disease in HIV Infection
por: Alfano, Gaetano, et al.
Publicado: (2019)

Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
por: Di Lullo, Luca, et al.
Publicado: (2015)

Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients
por: Bellasi, Antonio, et al.
Publicado: (2021)

Surveillance in testicular cancer: who, when, what and how?
por: Sohaib, S.A., et al.
Publicado: (2007)

Surgery: To what extent can we operate?
por: Kakeji, Yoshihiro
Publicado: (2018)

When, How, and to What Extent Are Individuals with Unresponsive Wakefulness Syndrome Able to Progress? Functional Independence
por: Olaya, José, et al.
Publicado: (2020)

When, How, and to What Extent Are Individuals with Unresponsive Wakefulness Syndrome Able to Progress? Neurobehavioral Progress
por: Noé, Enrique, et al.
Publicado: (2021)

Chronic Kidney Disease—How Does It Go, and What Can We Do and Expect?
por: Chang, Li-Yun, et al.
Publicado: (2023)

Heart attack guidance for physicians: When to suspect, how to diagnose, what to do?
por: Aggarwal, K.K., et al.
Publicado: (2017)

Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021)

Aiming for the end of the COVID-19 pandemic: the what, how, who, where, and when
por: Soriano, Joan B., et al.
Publicado: (2023)

To what Extent Would PBL be Best Incorporated into a Pharmacy Curriculum?
por: Vatanpour, Hossein
Publicado: (2012)

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020)

Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines
por: Morrone, Luigi Francesco, et al.
Publicado: (2011)

To what extent can telerehabilitation help patients in low- and middle-income countries?
por: Fernandes, Lívia G., et al.
Publicado: (2021)

To what extent does endoscopic tattooing marking boost lymph node retrieval?
por: Jung, Won Beom
Publicado: (2023)

What? When? And How?
por: Hutchinson, Jonathan
Publicado: (1890)

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2011)

Arterial Stiffness in Chronic Kidney Disease: The Usefulness of a Marker of Vascular Damage
por: Bellasi, Antonio, et al.
Publicado: (2011)

When and how to Screen!
por: Ekbom, A.
Publicado: (2020)

Chronic disease prevention in primary care: how and when will genomics impact?
por: Walter, Fiona M, et al.
Publicado: (2014)

Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
por: Magliocca, Giorgia, et al.
Publicado: (2022)

Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
por: D'Marco, Luis, et al.
Publicado: (2015)

Kidney and Phosphate Metabolism
por: Choi, Nak-Won
Publicado: (2008)

Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The “Nutritional Light Signal” of the Renal Acid Load
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2017)

Chronic Kidney Disease in Patients with Chronic Liver Disease: What Is the Price Tag?
por: Wong, Robert J., et al.
Publicado: (2020)

Data citation: what, when, why?
por: Lemberger, Thomas
Publicado: (2018)

What happens when the stories stop?
por: Westgarth, David
Publicado: (2021)

Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021)

Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
por: Rapa, Shara Francesca, et al.
Publicado: (2019)

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
por: Dirks, Niek F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m0a5dk5vob7d414lqi0tioj5o6